04:15 PM EDT, 04/01/2024 (MT Newswires) -- Gain Therapeutics ( GANX ) said Monday it has appointed Jonas Hannestad as its chief medical officer, effective March 25.
Hannestad previously served as chief medical officer at Tranquis Therapeutics and Capacity Bio, the company said.
Price: 3.98, Change: +0.15, Percent Change: +3.87